CRON Q1 2022 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena

CRONCronos Group Inc.

$983M

Q1 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$28M+79.1% YoY

Gross Profit

$8M29.6% margin

Operating Income

-$40M-139.9% margin

Net Income

-$41M-143.7% margin

EPS (Diluted)

$-0.09

QoQ Revenue Growth

-13.0%

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$35M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$62M

Stockholders' Equity

$1.7B

Cash & Equivalents

$1.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$16M	+79.1%
Gross Profit	$8M	-$4M	+325.3%
Operating Income	-$40M	-$57M	+30.1%
Net Income	-$41M	-$203M	+79.9%

Revenue Segments

Cannabis Flower

$19M74%

Cannabis Extracts

$6M25%

Product and Service, Other

$92,0000%

Geographic Segments

CANADA

$14M54%

ISRAEL

$9M36%

UNITED STATES

$2M9%